- Research works
- 37 ▲ 457% vs 2013–17
- Citations
- 529 14.4 per fractional work
- Top-10% rate
- 36.7% record average 16.5%
- Open access
- 72% world 28%
Not ranked overall: Celyad (Belgium) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Who are the top researchers at Celyad (Belgium)?
Ranked on the composite score, David E. Gilham lead among researchers whose main affiliation is Celyad (Belgium).
- 1 David E. Gilham Belgium · #809,506 worldwide 24 citations · 16 works
Which keywords describe research at Celyad (Belgium)?
By fractional works in all years, weighted toward what it does more of than the world: Cancer Immunotherapy, Lymphoma, CAR T Cells, Chimeric Antigen Receptor, Natural Killer Cells, NK Cell Recognition, Antigen Presentation and Gene Therapy.
- Glycosylation
- Genome Engineering
- Gene Silencing
- Immunity
- Gene Therapy
- Natural Killer Cells
- Chimeric Antigen Receptor
- Lymphoma
- Cancer Immunotherapy
- CAR T Cells
- NK Cell Recognition
- Antigen Presentation
- Dendritic Cells
- RNA Interference
- siRNA Delivery
- RNA-Guided
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 16 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 16 words, with their numbers
- Cancer Immunotherapy17▲ 335×3 topics
- Lymphoma16▲ 283×2 topics
- CAR T Cells15▲ 942×1 topic
- Chimeric Antigen Receptor15▲ 942×1 topic
- NK Cell Recognition6▲ 162×1 topic
- Natural Killer Cells6▲ 162×1 topic
- Antigen Presentation2▲ 64×2 topics
- Gene Therapy2▲ 24×2 topics
- Dendritic Cells2▲ 51×1 topic
- Immunity2▲ 17×1 topic
- RNA Interference2▲ 43×2 topics
- Gene Silencing2▲ 39×1 topic
- siRNA Delivery2▲ 62×1 topic
- Genome Engineering1▲ 67×1 topic
- RNA-Guided1▲ 67×1 topic
- Glycosylation1▲ 16×2 topics
Which research topics does Celyad (Belgium) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Immune Cell Function and Interaction, CRISPR and Genetic Engineering and Immunotherapy and Immune Responses.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 5 works
- 2 Immune Cell Function and Interaction Immunology 2 works
- 3 CRISPR and Genetic Engineering Molecular Biology 1 works
- 4 Immunotherapy and Immune Responses Immunology 1 works
- 5 RNA Interference and Gene Delivery Molecular Biology 1 works
- 6 Virus-based gene therapy research Genetics 0 works
- 7 Cancer Immunotherapy and Biomarkers Oncology 0 works
- 8 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 0 works
- 9 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 10 Advanced biosensing and bioanalysis techniques Molecular Biology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Celyad (Belgium)'s research output changed?
Output in 2018–2022 was 457% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Mont-Saint-Guibert
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.